914358-72-8 Usage
General Description
The chemical 5-Bromo-3-Chloro-2-Methylpyridine is a heterocyclic compound belonging to the pyridine family. It is a highly reactive and versatile intermediate used in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. Its unique structure and functional groups make it an important building block for the creation of various organic compounds. Additionally, its bromo and chloro substituents make it useful for cross-coupling reactions and the creation of diverse chemical compounds. 5-BROMO-3-CHLORO-2-METHYLPYRIDINE is also used as a reagent in organic synthesis and medicinal chemistry, making it a valuable tool for the development of new and innovative molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 914358-72-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,4,3,5 and 8 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 914358-72:
(8*9)+(7*1)+(6*4)+(5*3)+(4*5)+(3*8)+(2*7)+(1*2)=178
178 % 10 = 8
So 914358-72-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H5BrClN/c1-4-6(8)2-5(7)3-9-4/h2-3H,1H3
914358-72-8Relevant articles and documents
Compounds and their use as BACE Inhibitors
-
Page/Page column 32, (2012/07/13)
The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.
